Danimer Scientific Statistics
Total Valuation
Danimer Scientific has a market cap or net worth of 5.19 million. The enterprise value is 396.04 million.
| Market Cap | 5.19M |
| Enterprise Value | 396.04M |
Important Dates
The next estimated earnings date is Friday, March 28, 2025.
| Earnings Date | Mar 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Danimer Scientific has 3.02 million shares outstanding. The number of shares has increased by 8.57% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 3.02M |
| Shares Change (YoY) | +8.57% |
| Shares Change (QoQ) | +2.79% |
| Owned by Insiders (%) | 9.46% |
| Owned by Institutions (%) | 15.58% |
| Float | 2.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.13 |
| PB Ratio | 0.02 |
| P/TBV Ratio | 0.04 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.56 |
| EV / Sales | 10.58 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.51 |
Financial Position
The company has a current ratio of 3.28, with a Debt / Equity ratio of 1.95.
| Current Ratio | 3.28 |
| Quick Ratio | 1.80 |
| Debt / Equity | 1.95 |
| Debt / EBITDA | n/a |
| Debt / FCF | -5.75 |
| Interest Coverage | -2.41 |
Financial Efficiency
Return on equity (ROE) is -43.11% and return on invested capital (ROIC) is -8.14%.
| Return on Equity (ROE) | -43.11% |
| Return on Assets (ROA) | -7.96% |
| Return on Capital (ROIC) | -8.14% |
| Revenue Per Employee | 145,630 |
| Profits Per Employee | -432,673 |
| Employee Count | 257 |
| Asset Turnover | 0.05 |
| Inventory Turnover | 2.33 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -93.99% in the last 52 weeks. The beta is 1.61, so Danimer Scientific's price volatility has been higher than the market average.
| Beta (5Y) | 1.61 |
| 52-Week Price Change | -93.99% |
| 50-Day Moving Average | 4.88 |
| 200-Day Moving Average | 18.05 |
| Relative Strength Index (RSI) | 35.24 |
| Average Volume (20 Days) | 159,186 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.47 |
Income Statement
In the last 12 months, Danimer Scientific had revenue of 37.43 million and -111.20 million in losses. Loss per share was -40.24.
| Revenue | 37.43M |
| Gross Profit | -23.92M |
| Operating Income | -86.87M |
| Pretax Income | -111.19M |
| Net Income | -111.20M |
| EBITDA | -57.16M |
| EBIT | -86.87M |
| Loss Per Share | -40.24 |
Balance Sheet
The company has 22.19 million in cash and 413.04 million in debt, giving a net cash position of -390.85 million or -129.43 per share.
| Cash & Cash Equivalents | 22.19M |
| Total Debt | 413.04M |
| Net Cash | -390.85M |
| Net Cash Per Share | -129.43 |
| Equity (Book Value) | 211.59M |
| Book Value Per Share | 70.08 |
| Working Capital | 48.54M |
Cash Flow
In the last 12 months, operating cash flow was -62.39 million and capital expenditures -9.45 million, giving a free cash flow of -71.84 million.
| Operating Cash Flow | -62.39M |
| Capital Expenditures | -9.45M |
| Free Cash Flow | -71.84M |
| FCF Per Share | -23.79 |
Margins
Gross margin is -63.92%, with operating and profit margins of -232.12% and -297.10%.
| Gross Margin | -63.92% |
| Operating Margin | -232.12% |
| Pretax Margin | -297.08% |
| Profit Margin | -297.10% |
| EBITDA Margin | -152.72% |
| EBIT Margin | -232.12% |
| FCF Margin | n/a |
Dividends & Yields
Danimer Scientific does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.57% |
| Shareholder Yield | -8.57% |
| Earnings Yield | -2,339.41% |
| FCF Yield | -1,383.12% |
Stock Splits
The last stock split was on November 13, 2024. It was a reverse split with a ratio of 0.025.
| Last Split Date | Nov 13, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.025 |
Scores
Danimer Scientific has an Altman Z-Score of -1.31. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.31 |
| Piotroski F-Score | n/a |